Broker predictions/Pound of flesh, page-2

Missed a word in bold in my previous post which seems pretty important, i'm sure there were others, apologies.

If the Astrazenica partnership fails or the FDA denies Vivagel in the US Starpharma could be infor a huge SP drop and large shareholders could look for their pound of flesh.

I for one would like to see Astrazenica go from exploring our technology to getting their butts into gear to utilise and advance the technology to the clinic and my post is my frustration. Looking forward to the AGM to see if Starpharma can fix its communication faults.